Trial · NCT00567255
Results by group40
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 40
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Co-primary: Body Weight- Mean Percent Change From Baseline to Week 28 | NB32 | -6.45 | Standard Error 0.20 | percentage of body weight | |
| Co-primary: Body Weight- Mean Percent Change From Baseline to Week 28 | Placebo | -1.89 | Standard Error 0.26 | percentage of body weight | |
| Body Weight- Mean Percent Change From Baseline to Week 56 | NB32 | -6.40 | Standard Error 0.25 | percentage of body weight | |
| Body Weight- Mean Percent Change From Baseline to Week 56 | Placebo | -1.23 | Standard Error 0.33 | percentage of body weight | |
| Co-primary: Body Weight- Proportion of Subjects With ≥5% Decrease From Baseline to Week 28 | NB32 | 55.64 | 95% Confidence Interval 52.25 to 59.03 | percentage of participants | |
| Co-primary: Body Weight- Proportion of Subjects With ≥5% Decrease From Baseline to Week 28 | Placebo | 17.54 | 95% Confidence Interval 14.05 to 21.03 | percentage of participants | |
| Body Weight- Proportion of Subjects With ≥5% Decrease From Baseline to Week 56 | NB32 | 50.48 | 95% Confidence Interval 46.90 to 54.07 | percentage of participants | |
| Body Weight- Proportion of Subjects With ≥5% Decrease From Baseline to Week 56 | Placebo | 17.11 | 95% Confidence Interval 13.46 to 20.75 | percentage of participants | |
| Body Weight- Proportion of Subjects With ≥10% Decrease From Baseline to Week 28 | NB32 | 27.27 | 95% Confidence Interval 24.23 to 30.31 | percentage of participants | |
| Body Weight- Proportion of Subjects With ≥10% Decrease From Baseline to Week 28 | Placebo | 7.02 | 95% Confidence Interval 4.67 to 9.36 | percentage of participants | |
| Change in Waist Circumference | NB32 | -6.16 | Standard Error 0.28 | cm | |
| Change in Waist Circumference | Placebo | -2.74 | Standard Error 0.38 | cm | |
| Change in Fasting HDL Cholesterol Levels | NB32 | 1.19 | Standard Error 0.30 | mg/dL | |
| Change in Fasting HDL Cholesterol Levels | Placebo | -1.40 | Standard Error 0.42 | mg/dL | |
| Change in Fasting Triglycerides Levels, Using Log-transformed Data | NB32 | -7.32 | 95% Confidence Interval -9.80 to -4.76 | percent change | |
| Change in Fasting Triglycerides Levels, Using Log-transformed Data | Placebo | -1.36 | 95% Confidence Interval -5.02 to 2.43 | percent change | |
| Change in IWQOL-Lite Total Scores | NB32 | 9.94 | Standard Error 0.41 | units on a scale | |
| Change in IWQOL-Lite Total Scores | Placebo | 6.17 | Standard Error 0.56 | units on a scale | |
| Change in High-sensitivity C Reactive Protein (Hs-CRP) Levels, Using Log-transformed Data | NB32 | -9.38 | 95% Confidence Interval -14.78 to -3.63 | percent change | |
| Change in High-sensitivity C Reactive Protein (Hs-CRP) Levels, Using Log-transformed Data | Placebo | -1.14 | 95% Confidence Interval -9.11 to 7.52 | percent change |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00567255/results